Berlin, Germany

Werner Skuballa

This inventor holds 106 USPTO granted patents and 1 published patent application, primarily in Pharmaceutical Chemistry (CPC class 514573). Top assignees: Schering Aktiengesellschaft, Bayer Schering Pharma Ag, Bayer Pharma Aktiengesellschaft. Active years: 1976-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Werner Skuballa. Retrieved from https://idiyas.com/inventor/werner-skuballa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 106 

% Patents Active = 78.3

Average Co-Inventor Count = 5.3

ph-index = 13

Forward Citations = 538(Granted Patents)

Forward Citations (Not Self Cited) = 469(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Company Filing History:


Years Active: 1976-2012

Loading Chart...
Areas of Expertise:
Anti-Inflammatory Agents
Epothilone Derivatives
Leukotriene Compounds
Tetrahydronaphthalene
Heteroaromatic Esters
Pyridine Compounds
Prostaglandin Derivatives
Quinoline Derivatives
Chiral Compounds
Nonsteroidal Agents
Pharmaceutical Preparations
Chemical Processes
106 patents (USPTO):Explore Patents

Certainly, I can help with that. Here is the article about inventor Werner Skuballa:

Title: The Inventive Journey of Werner Skuballa: Pioneering Innovations in Berlin

Introduction:

Werner Skuballa, a prolific inventor based in Berlin, Germany, has made significant contributions to the field of pharmaceuticals with his numerous patented inventions. With a total of 106 patents to his name, Skuballa's innovative spirit and dedication to advancing anti-inflammatory agents have solidified his position as a trailblazer in the industry.

Latest Patents:

1. Multiply-substituted tetrahydronaphthalene derivatives: Skuballa's invention of multiply-substituted tetrahydronaphthalene derivatives of formula (I) showcases his expertise in developing novel compounds for anti-inflammatory purposes.

2. Optically active, heteroaromatic β-hydroxy esters: Skuballa's groundbreaking work on optically active heteroaromatic β-hydroxy esters has paved the way for the synthesis of epothilone derivatives, demonstrating his commitment to pushing the boundaries of pharmaceutical innovation.

Career Highlights:

Skuballa's illustrious career includes stints at reputable pharmaceutical companies such as Schering Aktiengesellschaft and Bayer Schering Pharma AG. His tenure at these organizations provided him with valuable industry experience and a platform to transform his inventive ideas into tangible innovations that have had a profound impact on the healthcare landscape.

Collaborations:

Throughout his career, Skuballa has collaborated with esteemed professionals in the field, including Helmut Vorbrueggen and Bernd Buchmann. Together, these visionaries have worked tirelessly to develop cutting-edge pharmaceutical solutions that address complex medical needs and improve patient outcomes.

Conclusion:

In conclusion, Werner Skuballa's impressive portfolio of patents and his dedication to advancing the field of anti-inflammatory agents underscore his status as a pioneering inventor in the pharmaceutical industry. His innovative spirit, coupled with his collaborative efforts and industry expertise, continues to shape the future of healthcare and inspire the next generation of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…